Home » Topics » BioWorld Science

BioWorld Science
RSS

Beijing Kawin Technology Share-Holding discloses anti-IL-4RA antibodies

Aug. 30, 2019

Janssen discloses tau-binding molecules

Aug. 30, 2019

New DNA-CAR modified T cells presented by Arizona State University

Aug. 30, 2019

NeuracleGenetics describes new programmed cell death protein-1 variants

Aug. 30, 2019

Preclinical and first clinical data for the novel Ox1R antagonist, JNJ-61393215

Aug. 30, 2019

Shanghai Dongxi Zhihui Biological Medicine patents beta-amyloid production inhibitors

Aug. 30, 2019

New antifilarials CBR-417 and CBR-490 validated in models in vivo

Aug. 30, 2019

Denali Therapeutics synthesizes brain-penetrant LRRK2 kinase inhibitors for the treatment of PD

Aug. 30, 2019

Mirati Therapeutics compounds target the PRC2 EED binding site

Aug. 30, 2019

La Jolla Pharmaceutical receives European approval for Giapreza

Aug. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...